Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
0.768
-0.019 (-2.38%)
At close: Mar 6, 2026, 4:00 PM EST
0.758
-0.009 (-1.22%)
After-hours: Mar 6, 2026, 4:00 PM EST
Evogene Employees
Evogene had 117 employees as of December 31, 2024. The number of employees decreased by 25 or -17.61% compared to the previous year.
Employees
117
Change (1Y)
-25
Growth (1Y)
-17.61%
Revenue / Employee
$68,513
Profits / Employee
-$23,496
Market Cap
6.93M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| KALA BIO | 38 |
| Kiora Pharmaceuticals | 12 |
| XTL Biopharmaceuticals | 10 |
| Alzamend Neuro | 7 |
| Mustang Bio | 6 |
| PharmaCyte Biotech | 2 |
| Addex Therapeutics | 2 |
| Pulmatrix | 2 |
EVGN News
- 1 day ago - Evogene Ltd. (EVGN) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 2 days ago - Evogene (EVGN) Focuses on Key Markets Following Strategic Shift - GuruFocus
- 2 days ago - Evogene Earnings Review: Q4 Summary - Benzinga
- 2 days ago - Evogene Reports Fourth Quarter and Full Year 2025 Financial Results - PRNewsWire
- 3 days ago - An Overview of Evogene's Earnings - Benzinga
- 10 days ago - Evogene Releases CEO Letter to Shareholders - PRNewsWire
- 16 days ago - Evogene Schedules Fourth Quarter and Full Year 2025 Financial Results Release - PRNewsWire
- 18 days ago - Evogene (EVGN) Partners with QUT to Combat Lung Cancer Drug Resistance - GuruFocus